Analyst Ryan MacDonald from Needham maintained a Buy rating on Phreesia (PHR – Research Report) and keeping the price target at $29.00.Stay ...

Citi raised the firm’s price target on Phreesia (PHR) to $35 from $31 and keeps a Buy rating on the shares as part of a 2025 outcook for the ...

From a technical perspective, Phreesia, Inc. (PHR) is looking like an interesting pick, as it just reached a key level of ...

Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients.

Phreesia (NYSE:PHR – Get Free Report) had its target price raised by investment analysts at KeyCorp from $28.00 to $30.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high ...

Fintel reports that on January 8, 2025, RBC Capital upgraded their outlook for Phreesia (NYSE:PHR) from Sector Perform to ...

One class action was filed against Deloitte Consulting and seven were filed against health care software company Phreesia and ...

Phreesia’s Q3 earnings show solid revenue growth, but customer growth is decelerating, impacting overall performance. Fiscal 2025 guidance improved with higher EBITDA and tighter revenue ...

Phreesia jumps 6% to $22.83 after Q3 results, updated guidance Phreesia narrows FY25 revenue view to $418M-$420M, consensus $419.1M Phreesia guides initial FY26 revenue $472M-$482M, consensus $480.5M ...

Phreesia, Inc. (NYSE:PHR – Get Free Report)’s stock price gapped up before the market opened on Tuesday following a better than expected earnings announcement. The stock had previously closed ...